
Gillanders Arbuthnot & Company: Analytical Review Highlights Mixed Signals Amid Market Pressure
2025-12-03 08:17:21Gillanders Arbuthnot & Company, a player in the FMCG sector, has experienced a shift in market assessment following recent analytical revisions. The company’s performance across quality, valuation, financial trends, and technical indicators presents a complex picture for investors navigating current market conditions.
Read MoreHow has been the historical performance of Gillanders Arbut?
2025-12-02 22:59:11Revenue and Operating Performance Trends Over the past six years, Gillanders Arbut's net sales have experienced notable volatility. The company recorded its peak sales in the fiscal year ending March 2019, with revenues exceeding ₹750 crores. However, this was followed by a sharp decline in subsequent years, with sales dropping to around ₹363 crores in March 2024 before rebounding to approximately ₹443 crores in March 2025. This fluctuation reflects the company's exposure to market dynamics and operational challenges. Operating profit margins have mirrored this variability. The operating profit margin excluding other income peaked at 8.7% in March 2019 but fell into negative territory in March 2024, registering a loss margin of over 9%. The margin recovered to 5.8% by ...
Read MoreWhy is Gillanders Arbut falling/rising?
2025-11-22 01:00:14Recent Price Movement and Market Comparison The stock’s decline on 21-Nov contrasts sharply with the broader market trend, as the Sensex recorded a modest gain of 0.79% over the past week. Gillanders Arbuthnot’s one-week return was negative at -6.52%, significantly underperforming the benchmark. This underperformance extends over longer periods as well, with the stock down 6.48% over the past month while the Sensex gained 0.95%. Year-to-date figures further highlight this divergence: the stock has declined by 7.33%, whereas the Sensex has risen by 9.08%. Even over the one-year horizon, the stock’s 7.94% gain lags behind the Sensex’s 10.47% appreciation. Despite this recent weakness, it is important to note that Gillanders Arbuthnot has delivered strong long-term return...
Read MoreIs Gillanders Arbut overvalued or undervalued?
2025-11-17 08:09:59As of 14 November 2025, the valuation grade for Gillanders Arbut has moved from very attractive to attractive. The company is currently considered fairly valued. Key ratios include a PE ratio of 19.64, an EV to EBITDA of 16.54, and a PEG ratio of 0.14, which suggests that the stock may still hold potential for growth relative to its price. In comparison to peers, Gillanders Arbut's PE ratio is significantly lower than that of Adani Enterprises at 139.01 and SRF at 51.93, both of which are classified as expensive. Additionally, Tata Chemicals, which is rated very attractive, has a PE ratio of 57.44, further emphasizing Gillanders Arbut's relative valuation position. Notably, Gillanders Arbut has outperformed the Sensex over the past year with a return of 18.73% compared to the Sensex's 9.00%, reinforcing its attractiveness in the market....
Read More
Gillanders Arbuthnot Adjusts Valuation Grade Amid Strong Market Performance and Competitive Metrics
2025-11-17 08:01:24Gillanders Arbuthnot & Company, a microcap in the FMCG sector, has adjusted its valuation, currently priced at 125.85. Over the past year, it achieved an 18.73% stock return, outperforming the Sensex. Key metrics indicate a competitive position, with a low PEG ratio suggesting growth potential relative to earnings.
Read MoreIs Gillanders Arbut overvalued or undervalued?
2025-11-16 08:09:30As of 14 November 2025, the valuation grade for Gillanders Arbut has moved from very attractive to attractive. The company is currently assessed as undervalued. Key ratios include a PE Ratio of 19.64, an EV to EBITDA of 16.54, and a PEG Ratio of 0.14, which indicates strong growth potential relative to its price. In comparison to peers, Gillanders Arbut's PE Ratio is significantly lower than Adani Enterprises, which stands at 139.01, and SRF, with a PE of 51.93, both categorized as expensive. Additionally, Tata Chemicals, rated very attractive, has a PE of 57.44, further highlighting Gillanders Arbut's relative undervaluation. Notably, the company's stock has outperformed the Sensex over the past year, returning 18.73% compared to the Sensex's 9.00%, reinforcing its favorable valuation outlook....
Read MoreIs Gillanders Arbut overvalued or undervalued?
2025-11-15 08:09:40As of 14 November 2025, Gillanders Arbut has moved from a very attractive to an attractive valuation grade. The company is currently considered undervalued based on its financial ratios, which include a PE Ratio of 19.64, an EV to EBITDA of 16.54, and a PEG Ratio of 0.14. These figures suggest that the company is trading at a reasonable valuation compared to its earnings growth potential. In comparison to its peers, Gillanders Arbut's valuation appears favorable. For instance, Adani Enterprises has a significantly higher PE Ratio of 139.01, while Tata Chemicals, considered very attractive, has a PE Ratio of 57.44. Additionally, the company's recent stock performance has outpaced the Sensex over the past year, with a return of 18.73% compared to the Sensex's 9.00%. This reinforces the notion that Gillanders Arbut is undervalued in the current market environment....
Read MoreWhy is Gillanders Arbut falling/rising?
2025-11-14 22:47:04As of 14-Nov, Gillanders Arbuthnot & Company Ltd is experiencing a price increase, currently at 125.85, reflecting a rise of 2.1 or 1.7%. The stock has outperformed its sector today by 1.48%, and its delivery volume has increased by 6.43% compared to the 5-day average, indicating rising investor participation. In terms of performance against benchmarks, the stock has shown a 1-week return of +6.02%, which significantly exceeds the Sensex's +1.62% for the same period. Additionally, the stock is trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. In the broader market context, while Gillanders Arbuthnot has had a year-to-date return of -0.87%, which is underperforming the Sensex's +8.22%, its longer-term performance is more favorable, with a 1-year return of +18.73% compared to the Sensex's +9.00%. The stock's impressive 3-year and 5-yea...
Read More
Gillanders Arbuthnot Reports Mixed Financial Trends Amid Strong Growth in Key Metrics
2025-11-14 11:02:49Gillanders Arbuthnot & Company, a microcap in the FMCG sector, reported strong financial results for the quarter ending September 2025, with significant growth in Profit Before Tax and Profit After Tax. However, it faced a decline in PAT over the past six months and a low Debtors Turnover Ratio. The stock has outperformed the Sensex over one and three years.
Read MoreBoard Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31.12.2025.
30-Jan-2026 | Source : BSEGillanders Arbuthnot & Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended on 31.12.2025.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Jan-2026 | Source : BSEPlease find attached certificate as issued by the RTA for quarter ended 31.12.2025
Closure of Trading Window
22-Dec-2025 | Source : BSEPursuant to SEBI (PIT) Regulations 2015 and the Companys Code of Conduct for Prohibition of Insider Trading the trading window for dealing in the securities of the Company will remain closed from 01.01.2026 till 48 hours from announcement to the stock exchanges the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ending on 31.12.2025.
Corporate Actions
No Upcoming Board Meetings
Gillanders Arbuthnot & Company Ltd has declared 7% dividend, ex-date: 05 Aug 14
No Splits history available
Gillanders Arbuthnot & Company Ltd has announced 1:2 bonus issue, ex-date: 14 Sep 10
No Rights history available